drugset / Trial / NCT01485601
Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to find an optimal dose to determine the safety and tolerability of a single dose of MT10109(clostridium botulinum type A) administered by intramuscular injection in subjects with glabellar lines compared with the standard dose of BOTOX®
Timeline
- Start
- 2011-12-07
- Primary completion
- 2012-03-30
- Completion
- 2012-08-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NivobotulinumtoxinA | Protein / enzyme biologic | — | Intramuscular |
Indications
No indication recorded.